Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab.
about
Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel biomarker and easy to pe ...... drome treated with eculizumab.
@en
type
label
Novel biomarker and easy to pe ...... drome treated with eculizumab.
@en
prefLabel
Novel biomarker and easy to pe ...... drome treated with eculizumab.
@en
P2093
P2860
P1476
Novel biomarker and easy to pe ...... ndrome treated with eculizumab
@en
P2093
Alejandra Rosales
Dorothea Heininger
Giacomo D Simonetti
Johannes Hofer
Karsten Häffner
Lambert van den Heuvel
Lothar B Zimmerhackl
Magdalena Riedl
Reinhard Würzner
Tanja Maier
P2860
P356
10.1016/J.JIM.2016.05.009
P577
2016-05-26T00:00:00Z